July 21, 2026 a 07:43 am
MDT: Fundamental Ratio Analysis - Medtronic plc
Medtronic plc stands as a leader in the medical technology field. With innovative solutions across cardiovascular, surgical, neuroscience, and diabetes management, the company addresses critical healthcare needs globally. Its diverse portfolio and steady financial fundamentals make it a pivotal player in the healthcare sector.
Fundamental Rating
The fundamental data for Medtronic plc suggest a balanced performance across various financial metrics, reflecting moderate growth potential but some areas needing attention.
| Category | Score | Visualization |
|---|---|---|
| Discounted Cash Flow | 5 | |
| Return on Equity | 3 | |
| Return on Assets | 4 | |
| Debt to Equity | 1 | |
| Price to Earnings | 2 | |
| Price to Book | 3 |
Historical Rating
The historical ratings give insight into how Medtronic plc's financial evaluations and metrics have evolved, maintaining consistency over recent periods.
| Date | Overall Score | DCF | ROE | ROA | Debt to Equity | P/E | P/B |
|---|---|---|---|---|---|---|---|
| 2026-07-20 | 3 | 5 | 3 | 4 | 1 | 2 | 3 |
| N/A | 0 | 5 | 3 | 4 | 1 | 2 | 3 |
Analyst Price Targets
Analyst projections indicate a positive outlook for Medtronic plc, with room for stock price growth as highlighted by their price target ranges.
| High | Low | Median | Consensus |
|---|---|---|---|
| 119 | 80 | 91 | 95.8 |
Analyst Ratings
The current analyst sentiment reflects a favorable view of Medtronic plc, with a strong tendency towards Buy recommendations.
| Recommendation | Count | Distribution |
|---|---|---|
| Strong Buy | 1 | |
| Buy | 29 | |
| Hold | 21 | |
| Sell | 0 | |
| Strong Sell | 0 |
Conclusion
Medtronic plc presents a balanced investment opportunity with strong footholds in multiple medical device sectors. Its consistent financial ratings and positive analyst sentiment underscore potential for moderate growth. However, certain financial metrics suggest that strategic improvements could further enhance its performance. Despite some risks inherent in financial leveraging, the company's innovation across medical specialties provides robust avenues for future expansion.
Smart Data Insight
Master the Perfect Entry & Exit for this Stock
Don't leave your profits to chance. Historically, this stock follows specific seasonal patterns that institutional traders use to maximize returns.
- ✅ Identify the "Golden Buying Window"
- ✅ Avoid high-risk correction cycles
- ✅ Backtested data from the last 20+ years